[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various cancers. The company's two clinical programs Amezalpat formerly PST-1120, an oral, small molecule, selective antagonist of peroxisome proliferator-activated receptor alpha, which is in Phase III; and TPST-1495, a novel, small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, which is in Phase II. The company has agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq) and bevacizumab. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 923235, "exercisedValue": 0, "unexercisedValue": 262204}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 43, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 465429, "exercisedValue": 0, "unexercisedValue": 67328}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 57, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 667651, "exercisedValue": 0, "unexercisedValue": 93438}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 36, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.85, "open": 7.025, "dayLow": 6.65, "dayHigh": 7.23, "regularMarketPreviousClose": 6.85, "regularMarketOpen": 7.025, "regularMarketDayLow": 6.65, "regularMarketDayHigh": 7.23, "payoutRatio": 0.0, "beta": -2.283, "forwardPE": -5.065217, "volume": 57562, "regularMarketVolume": 57562, "averageVolume": 62768, "averageVolume10days": 60840, "averageDailyVolume10Day": 60840, "bid": 5.21, "ask": 8.57, "bidSize": 2, "askSize": 2, "marketCap": 24607036, "fiftyTwoWeekLow": 5.356, "fiftyTwoWeekHigh": 49.27, "fiftyDayAverage": 9.17922, "twoHundredDayAverage": 13.411495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9553074, "profitMargins": 0.0, "floatShares": 3222289, "sharesOutstanding": 3520320, "sharesShort": 110022, "sharesShortPriorMonth": 134803, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0313, "heldPercentInsiders": 0.00133, "heldPercentInstitutions": 0.14272, "shortRatio": 1.49, "shortPercentOfFloat": 0.0339, "impliedSharesOutstanding": 3520320, "bookValue": 5.655, "priceToBook": 1.2360742, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -41843000, "trailingEps": -19.5, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.229, "52WeekChange": -0.8558466, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 6.99, "targetHighPrice": 207.99994, "targetLowPrice": 9.0, "targetMeanPrice": 102.99997, "targetMedianPrice": 97.49997, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 30268000, "totalCashPerShare": 8.651, "ebitda": -41637000, "totalDebt": 15365000, "quickRatio": 2.129, "currentRatio": 2.213, "debtToEquity": 80.336, "returnOnAssets": -0.56431, "returnOnEquity": -1.82346, "freeCashflow": -19081750, "operatingCashflow": -33027000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746228800, "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Tempest Therapeutics, Inc.", "shortName": "Tempest Therapeutics, Inc.", "regularMarketChangePercent": 2.0437937, "regularMarketPrice": 6.99, "marketState": "CLOSED", "fiftyDayAverageChange": -2.1892204, "fiftyDayAverageChangePercent": -0.23849744, "twoHundredDayAverageChange": -6.4214954, "twoHundredDayAverageChangePercent": -0.47880533, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2025-05-02", "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": 0.143065, "postMarketPrice": 7.0, "postMarketChange": 0.0100002, "regularMarketChange": 0.13999987, "regularMarketDayRange": "6.65 - 7.23", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 62768, "fiftyTwoWeekLowChange": 1.6339998, "fiftyTwoWeekLowChangePercent": 0.3050784, "fiftyTwoWeekRange": "5.356 - 49.27", "fiftyTwoWeekHighChange": -42.28, "fiftyTwoWeekHighChangePercent": -0.85812867, "fiftyTwoWeekChangePercent": -85.584656, "dividendDate": 1544400000, "earningsTimestamp": 1743106257, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -19.5, "epsForward": -1.38, "epsCurrentYear": -13.66333, "priceEpsCurrentYear": -0.5115883, "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]